chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: arm is hurting after getting the second dose of Moderna covid19 vaccine; headaches; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (arm is hurting after getting the second dose of Moderna covid19 vaccine) and HEADACHE (headaches) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET) for an unknown indication.   On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, the patient experienced MYALGIA (arm is hurting after getting the second dose of Moderna covid19 vaccine) and HEADACHE (headaches). At the time of the report, MYALGIA (arm is hurting after getting the second dose of Moderna covid19 vaccine) and HEADACHE (headaches) outcome was unknown.            No treatment was provided.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Decreased interest
Clinical narrative: Loss of interest in routine activities; little loss of memory and forget things.; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED INTEREST (Loss of interest in routine activities) and AMNESIA (little loss of memory and forget things.) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 039B?1A) for COVID-19 vaccination.     Concurrent medical conditions included Mental retardation.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2021, the patient experienced DECREASED INTEREST (Loss of interest in routine activities) and AMNESIA (little loss of memory and forget things.). At the time of the report, DECREASED INTEREST (Loss of interest in routine activities) and AMNESIA (little loss of memory and forget things.) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Moderna vaccine administered to an unauthorized age group (patient 13 years old); This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna vaccine administered to an unauthorized age group (patient 13 years old)) in a 13-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna vaccine administered to an unauthorized age group (patient 13 years old)). On 20-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna vaccine administered to an unauthorized age group (patient 13 years old)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter Treatment information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Tinnitus
Clinical narrative: Getting noise in her right ear/rattle noise in right ear; Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Getting noise in her right ear/rattle noise in right ear), MYALGIA (Body aches) and CHILLS (Chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 008B21A) for COVID-19 vaccination.     Concomitant products included SUMATRIPTAN (IMITREX [SUMATRIPTAN]) for an unknown indication.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced MYALGIA (Body aches) and CHILLS (Chills). On 07-May-2021, the patient experienced TINNITUS (Getting noise in her right ear/rattle noise in right ear). The patient was treated with IBUPROFEN at an unspecified dose and frequency and DIMENHYDRINATE (DRAMAMINE) at an unspecified dose and frequency. On 05-May-2021, MYALGIA (Body aches) and CHILLS (Chills) had resolved. At the time of the report, TINNITUS (Getting noise in her right ear/rattle noise in right ear) outcome was unknown.        Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Telephone Contact Report attached.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Diarrhoea, Drug ineffective, Headache, Heavy menstrual bleeding
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of SNEEZING (sneezing), BONE PAIN (bone pain), DIARRHEA (diarrhea), HEAVY MENSTRUAL BLEEDING (I had my menstrual period for 10 days and usually last four to five days) and DRUG INEFFECTIVE (lack of drug effect) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included PARACETAMOL (TYLENOL) for Paracetamol, IBUPROFEN for an unknown indication. On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced MYALGIA (very little arm pain), PYREXIA (fever) and HEADACHE (headache). On 17-May-2021, the patient experienced DRUG INEFFECTIVE (lack of drug effect). On an unknown date, the patient experienced SNEEZING (sneezing), BONE PAIN (bone pain), DIARRHOEA (diarrhea) and HEAVY MENSTRUAL BLEEDING (I had my menstrual period for 10 days and usually last four to five days). On 17-May-2021, DRUG INEFFECTIVE (lack of drug effect) outcome was unknown. At the time of the report, SNEEZING (sneezing), BONE PAIN (bone pain), DIARRHOEA (diarrhea), HEAVY MENSTRUAL BLEEDING (I had my menstrual period for 10 days and usually last four to five days), MYALGIA (very little arm pain), PYREXIA (fever) and HEADACHE (headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-May-2021, SARS-CoV-2 test: positive (Positive) Abnormal. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This case was linked to MOD-2021-154759. Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Upon internal review on 16 Jul 2021, an event (lack of efficacy) was added at Moderna's request.  Event of SARS-COV-2 TEST POSITIVE deleted as this is captured in relevant labs.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, SARS-CoV-2 test, Sneezing
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of SNEEZING (sneezing), BONE PAIN (bone pain), DIARRHEA (diarrhea), HEAVY MENSTRUAL BLEEDING (I had my menstrual period for 10 days and usually last four to five days) and DRUG INEFFECTIVE (lack of drug effect) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included PARACETAMOL (TYLENOL) for Paracetamol, IBUPROFEN for an unknown indication. On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced MYALGIA (very little arm pain), PYREXIA (fever) and HEADACHE (headache). On 17-May-2021, the patient experienced DRUG INEFFECTIVE (lack of drug effect). On an unknown date, the patient experienced SNEEZING (sneezing), BONE PAIN (bone pain), DIARRHOEA (diarrhea) and HEAVY MENSTRUAL BLEEDING (I had my menstrual period for 10 days and usually last four to five days). On 17-May-2021, DRUG INEFFECTIVE (lack of drug effect) outcome was unknown. At the time of the report, SNEEZING (sneezing), BONE PAIN (bone pain), DIARRHOEA (diarrhea), HEAVY MENSTRUAL BLEEDING (I had my menstrual period for 10 days and usually last four to five days), MYALGIA (very little arm pain), PYREXIA (fever) and HEADACHE (headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-May-2021, SARS-CoV-2 test: positive (Positive) Abnormal. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This case was linked to MOD-2021-154759. Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Upon internal review on 16 Jul 2021, an event (lack of efficacy) was added at Moderna's request.  Event of SARS-COV-2 TEST POSITIVE deleted as this is captured in relevant labs.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthma, Hypokinesia
Clinical narrative: Asthma kicked in,2 hours later and then 3 hours after that she had another attack; it's tough to make a fist; excruciating pain in shoulders, arms, and wrists; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthma kicked in,2 hours later and then 3 hours after that she had another attack), HYPOKINESIA (it's tough to make a fist) and ARTHRALGIA (excruciating pain in shoulders, arms, and wrists) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     The patient's past medical history included Cancer. Concurrent medical conditions included Arthritis and Asthma. Concomitant products included VALSARTAN for Blood pressure management, ROSUVASTATIN for Cholesterol.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced ASTHMA (Asthma kicked in,2 hours later and then 3 hours after that she had another attack), HYPOKINESIA (it's tough to make a fist) and ARTHRALGIA (excruciating pain in shoulders, arms, and wrists). The patient was treated with PREDNISONE at a dose of UNK dosage form. At the time of the report, ASTHMA (Asthma kicked in,2 hours later and then 3 hours after that she had another attack), HYPOKINESIA (it's tough to make a fist) and ARTHRALGIA (excruciating pain in shoulders, arms, and wrists) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: This spontaneous case reported by a pharmacist, describes the occurrence of inappropriate schedule of product (administered second dose 15 weeks after first one) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 001C21A) for COVID-19 immunization. No medical history reported. On Jan 19, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On May 5, 2021, patient experienced inappropriate schedule of product (administered second dose 15 weeks after first one). The reporter did not provide any causality assessments, treatment information or concomitant medication.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash, Vaccination site reaction
Clinical narrative: experienced "COVID arm" and her arm was tender, blotchy, and red.; arm was tender; arm was red; arm was blotchy; sore arm for a couple days.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (experienced "COVID arm" and her arm was tender, blotchy, and red.), VACCINATION SITE PAIN (sore arm for a couple days.), VACCINATION SITE PAIN (arm was tender), VACCINATION SITE ERYTHEMA (arm was red) and VACCINATION SITE RASH (arm was blotchy) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm for a couple days.). On 13-Apr-2021, the patient experienced VACCINATION SITE REACTION (experienced "COVID arm" and her arm was tender, blotchy, and red.), VACCINATION SITE PAIN (arm was tender), VACCINATION SITE ERYTHEMA (arm was red) and VACCINATION SITE RASH (arm was blotchy). At the time of the report, VACCINATION SITE REACTION (experienced "COVID arm" and her arm was tender, blotchy, and red.), VACCINATION SITE PAIN (sore arm for a couple days.), VACCINATION SITE PAIN (arm was tender), VACCINATION SITE ERYTHEMA (arm was red) and VACCINATION SITE RASH (arm was blotchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medication was provided. No treatment  was provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Nine patients received vaccine from punctured vial stored more than 12hours; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Nine patients received vaccine from punctured vial stored more than 12hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Nine patients received vaccine from punctured vial stored more than 12hours). On 22-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Nine patients received vaccine from punctured vial stored more than 12hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment was reported. pharmacist said the incidence happened 28days ago   This case was linked to US-MODERNATX, INC.-MOD-2021-154535 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-154535:Crosslink
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pyrexia, Vaccination site pain
Clinical narrative: body aches; delayed reaction of light fever of 99.3 F; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), VACCINATION SITE PAIN (Sore arm) and PYREXIA (delayed reaction of light fever of 99.3 F) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Sore arm). On 20-May-2021, the patient experienced PAIN (body aches) and PYREXIA (delayed reaction of light fever of 99.3 F). At the time of the report, PAIN (body aches) and PYREXIA (delayed reaction of light fever of 99.3 F) outcome was unknown and VACCINATION SITE PAIN (Sore arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-May-2021, Body temperature: 99.3 (High) 99.3 F.         No concomitant details were provided No treatment details were provided   This case was linked to MOD-2021-154924 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site lymphadenopathy
Clinical narrative: swollen lymph node in injection arms; swollen lymph nodes in neck.; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (swollen lymph node in injection arms) and LYMPHADENOPATHY (swollen lymph nodes in neck.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE LYMPHADENOPATHY (swollen lymph node in injection arms) and LYMPHADENOPATHY (swollen lymph nodes in neck.). At the time of the report, VACCINATION SITE LYMPHADENOPATHY (swollen lymph node in injection arms) and LYMPHADENOPATHY (swollen lymph nodes in neck.) outcome was unknown.            No concomitant medication is reported. No treatment medication is reported.   This case was linked to MOD-2021-154673 (Patient Link).   Reporter did not allow further contact
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Inappropriate schedule of product administration, Influenza like illness, Nausea
Clinical narrative: Missed dose; exceeded 35 day dosing window; sore throat with white pus, (strep negative); flu like symptoms; nausea; vomiting; headache; feverish; diarrhea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (exceeded 35 day dosing window), PRODUCT DOSE OMISSION ISSUE (Missed dose), OROPHARYNGEAL PAIN (sore throat with white pus, (strep negative)), INFLUENZA LIKE ILLNESS (flu like symptoms) and NAUSEA (nausea) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat with white pus, (strep negative)), INFLUENZA LIKE ILLNESS (flu like symptoms), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (headache), PYREXIA (feverish) and DIARRHOEA (diarrhea). On 20-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (exceeded 35 day dosing window). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dose). The patient was treated with AMOXICILLIN at an unspecified dose and frequency. On 23-Apr-2021, OROPHARYNGEAL PAIN (sore throat with white pus, (strep negative)), INFLUENZA LIKE ILLNESS (flu like symptoms), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (headache), PYREXIA (feverish) and DIARRHOEA (diarrhea) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (exceeded 35 day dosing window) and PRODUCT DOSE OMISSION ISSUE (Missed dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Amoxicillin was prescribed as treatment but patient did not use as prescribed.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Product dose omission issue, Pyrexia, Vomiting
Clinical narrative: Missed dose; exceeded 35 day dosing window; sore throat with white pus, (strep negative); flu like symptoms; nausea; vomiting; headache; feverish; diarrhea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (exceeded 35 day dosing window), PRODUCT DOSE OMISSION ISSUE (Missed dose), OROPHARYNGEAL PAIN (sore throat with white pus, (strep negative)), INFLUENZA LIKE ILLNESS (flu like symptoms) and NAUSEA (nausea) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat with white pus, (strep negative)), INFLUENZA LIKE ILLNESS (flu like symptoms), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (headache), PYREXIA (feverish) and DIARRHOEA (diarrhea). On 20-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (exceeded 35 day dosing window). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dose). The patient was treated with AMOXICILLIN at an unspecified dose and frequency. On 23-Apr-2021, OROPHARYNGEAL PAIN (sore throat with white pus, (strep negative)), INFLUENZA LIKE ILLNESS (flu like symptoms), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (headache), PYREXIA (feverish) and DIARRHOEA (diarrhea) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (exceeded 35 day dosing window) and PRODUCT DOSE OMISSION ISSUE (Missed dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Amoxicillin was prescribed as treatment but patient did not use as prescribed.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Feeling cold, Tremor
Clinical narrative: Uncontrollable shaking; Feeling very cold inside; Joints hurt really badly in his arm; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Uncontrollable shaking), FEELING COLD (Feeling very cold inside) and ARTHRALGIA (Joints hurt really badly in his arm) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21H) for COVID-19 vaccination.     No Medical History information was provided.    On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced TREMOR (Uncontrollable shaking), FEELING COLD (Feeling very cold inside) and ARTHRALGIA (Joints hurt really badly in his arm). On 20-May-2021, TREMOR (Uncontrollable shaking), FEELING COLD (Feeling very cold inside) and ARTHRALGIA (Joints hurt really badly in his arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medication information provided.  No treatment medication information provided.
Sex: M
Vaccine: COVID19
Symptoms: Product availability issue
Clinical narrative: got the first dose of the Moderna vaccine on 11Jan2021 and hasn´t received the second dose yet because the city run out of doses by the time they were supposed to get it; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT AVAILABILITY ISSUE (got the first dose of the Moderna vaccine on 11Jan2021 and hasn´t received the second dose yet because the city run out of doses by the time they were supposed to get it) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, the patient experienced PRODUCT AVAILABILITY ISSUE (got the first dose of the Moderna vaccine on 11Jan2021 and hasn´t received the second dose yet because the city run out of doses by the time they were supposed to get it). At the time of the report, PRODUCT AVAILABILITY ISSUE (got the first dose of the Moderna vaccine on 11Jan2021 and hasn´t received the second dose yet because the city run out of doses by the time they were supposed to get it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        Relevant concomitant product usage were not reported by the reporter. No treatment details were added.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergy headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 16-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, the patient experienced HYPERSENSITIVITY (Allergy headache). At the time of the report, HYPERSENSITIVITY (Allergy headache) outcome was unknown. The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable. No concomitant medications were reported. No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: the length of time between their first and second doses of the Moderna Covid 19 vaccine was longer than the 42 day window; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the length of time between their first and second doses of the Moderna Covid 19 vaccine was longer than the 42 day window) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 037B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the length of time between their first and second doses of the Moderna Covid 19 vaccine was longer than the 42 day window). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (the length of time between their first and second doses of the Moderna Covid 19 vaccine was longer than the 42 day window) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Non-significant follow up is added
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Feeling hot, Flushing, Hypoaesthesia
Clinical narrative: Itching; Tingling sensation; Numbness; Sneezing; cough; feeling hot; flushing; Generalized Rash; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), SNEEZING (Sneezing) and COUGH (cough) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching), PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), SNEEZING (Sneezing), COUGH (cough), FEELING HOT (feeling hot), FLUSHING (flushing), RASH (Generalized Rash) and CHILLS (Chills). At the time of the report, PRURITUS (Itching), PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), SNEEZING (Sneezing), COUGH (cough), FEELING HOT (feeling hot), FLUSHING (flushing), RASH (Generalized Rash) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  Antihistamines and steroids are the treatment medication reported by reporter.  Patient stated that on 15JUL2021, the events are recovered with residual effects like sneezing, itchy rash throughout the body   This case was linked to MOD-2021-154634 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: follow up received, additional events were added.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus, Rash, Sneezing
Clinical narrative: Itching; Tingling sensation; Numbness; Sneezing; cough; feeling hot; flushing; Generalized Rash; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), SNEEZING (Sneezing) and COUGH (cough) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching), PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), SNEEZING (Sneezing), COUGH (cough), FEELING HOT (feeling hot), FLUSHING (flushing), RASH (Generalized Rash) and CHILLS (Chills). At the time of the report, PRURITUS (Itching), PARAESTHESIA (Tingling sensation), HYPOAESTHESIA (Numbness), SNEEZING (Sneezing), COUGH (cough), FEELING HOT (feeling hot), FLUSHING (flushing), RASH (Generalized Rash) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  Antihistamines and steroids are the treatment medication reported by reporter.  Patient stated that on 15JUL2021, the events are recovered with residual effects like sneezing, itchy rash throughout the body   This case was linked to MOD-2021-154634 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: follow up received, additional events were added.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: chills; body ache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and MYALGIA (body ache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer (remission at this stage) since 2013. Concomitant products included ANASTROZOLE for Cancer, ATORVASTATIN for Cholesterolosis NOS.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced CHILLS (chills) and MYALGIA (body ache). On 07-Apr-2021, CHILLS (chills) had resolved. On 08-Apr-2021, MYALGIA (body ache) had resolved.            The patient reported symptoms of chills started about half an hour after the Covid 19 vaccine second dose. The chills were violent, and I could not control them, but the duration was only 15-20 minutes and they did not reoccur.  The body ache was normal to a flu and lasted into the evening, all symptoms were gone by morning. I was not alarmed as I knew of the reported side effects.   No information regarding corrective treatment was reported by the patient.   This case was linked to MOD-2021-155044 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Significant FU received contains updated information about patient demographics and her medical condition and concomitant medication and event outcome were updated.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody positive, Asthenia, Fatigue, Feeling abnormal, Headache
Clinical narrative: Very Lethargic; Weak; couldn't get out of bed,wasn't as active, and couldn't do things she could do before; Over exerted if I did things/very tired; Slept for 16 hours straight; Foggy; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-May-2021 and was forwarded to Moderna on 20-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Foggy), SOMNOLENCE (Slept for 16 hours straight), LETHARGY (Very Lethargic), ASTHENIA (Weak) and MOBILITY DECREASED (couldn't get out of bed,wasn't as active, and couldn't do things she could do before) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided by the reporter.     On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced HEADACHE (Headache). On 17-Apr-2021, the patient experienced FEELING ABNORMAL (Foggy). On 18-Apr-2021, the patient experienced SOMNOLENCE (Slept for 16 hours straight). On 19-Apr-2021, the patient experienced LETHARGY (Very Lethargic), ASTHENIA (Weak), MOBILITY DECREASED (couldn't get out of bed,wasn't as active, and couldn't do things she could do before) and FATIGUE (Over exerted if I did things/very tired). On 16-Apr-2021, HEADACHE (Headache) had resolved. On 18-Apr-2021, FEELING ABNORMAL (Foggy) and SOMNOLENCE (Slept for 16 hours straight) had resolved. On 17-May-2021, LETHARGY (Very Lethargic), ASTHENIA (Weak) and FATIGUE (Over exerted if I did things/very tired) had resolved. At the time of the report, MOBILITY DECREASED (couldn't get out of bed,wasn't as active, and couldn't do things she could do before) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, Antinuclear antibody positive: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Mobility decreased, Somnolence
Clinical narrative: Very Lethargic; Weak; couldn't get out of bed,wasn't as active, and couldn't do things she could do before; Over exerted if I did things/very tired; Slept for 16 hours straight; Foggy; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-May-2021 and was forwarded to Moderna on 20-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Foggy), SOMNOLENCE (Slept for 16 hours straight), LETHARGY (Very Lethargic), ASTHENIA (Weak) and MOBILITY DECREASED (couldn't get out of bed,wasn't as active, and couldn't do things she could do before) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided by the reporter.     On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced HEADACHE (Headache). On 17-Apr-2021, the patient experienced FEELING ABNORMAL (Foggy). On 18-Apr-2021, the patient experienced SOMNOLENCE (Slept for 16 hours straight). On 19-Apr-2021, the patient experienced LETHARGY (Very Lethargic), ASTHENIA (Weak), MOBILITY DECREASED (couldn't get out of bed,wasn't as active, and couldn't do things she could do before) and FATIGUE (Over exerted if I did things/very tired). On 16-Apr-2021, HEADACHE (Headache) had resolved. On 18-Apr-2021, FEELING ABNORMAL (Foggy) and SOMNOLENCE (Slept for 16 hours straight) had resolved. On 17-May-2021, LETHARGY (Very Lethargic), ASTHENIA (Weak) and FATIGUE (Over exerted if I did things/very tired) had resolved. At the time of the report, MOBILITY DECREASED (couldn't get out of bed,wasn't as active, and couldn't do things she could do before) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Apr-2021, Antinuclear antibody positive: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: received his first dose of Moderna COVID-19 Vaccine on 27Jan2021 , has not received the second dose yet; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received his first dose of Moderna COVID-19 Vaccine on 27Jan2021 , has not received the second dose yet) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received his first dose of Moderna COVID-19 Vaccine on 27Jan2021 , has not received the second dose yet). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received his first dose of Moderna COVID-19 Vaccine on 27Jan2021 , has not received the second dose yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant product usage were not reported by the reporter. No treatment details were added.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Janssen given to minor
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hot flush, Injection site rash
Clinical narrative: Headache; chills; muscle aches; fatigue; hot flashes without fever; rash at injection site.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Headache; chills; muscle aches; fatigue; hot flashes without fever; rash at injection site.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema, Eye swelling
Clinical narrative: patient called pharmacy 8/21/21 after receiving pfizer covid 19 vaccine 8/18/21. Patient reported swelling of eyes and angioedema. Patient reported receiving steroid shot from a medical facility.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Headache, Pain, Pyrexia
Clinical narrative: Chills, body aches, headache, stomach ache, fever 102. Lasted over 24 hours
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Cardiolipin antibody
Clinical narrative: Second trimester miscarriage
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Eye movement disorder, Impaired work ability, Nausea, Vertigo, Vomiting
Clinical narrative: Was fine day of vaccine and morning after. Work night shift, so went to sleep around 1030am. Woke up at 3:30, turned over and started spinning. Made way to bathroom,  vomited.  Called for husband to help back to bed. Called in sick to work. Any movement, even just turning head caused spinning and nauseaand rapid eye movement. Lasted for around 16hours.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Thrombosis
Clinical narrative: Blood clot ,Stroke.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Parosmia, Taste disorder
Clinical narrative: Taste and smell is very off since I got the second vaccine. Everything smells and taste bad almost like burnt maple syrup mud dirt rancid. Everything that smells and tastes off has the same bad smell and taste. Coffee is the worst.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Chronic cough since second vaccine dose. Been tested regularly for Covid-19 at work and has always been negative, so COVID infection seems unlikely.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature increased, Chills, Headache
Clinical narrative: Temperature more than 100 Fahrenheit, chills, headache, weakness, temperature goes up and down every 30 minutes.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Moderna Covid-19 Vaccine EUA :Injection site reaction. Started with mild itching the same afternoon. I woke up at 1 am this morning to find the area around the injection site, 6 inches in diameter, red, hot and swollen, area firm to touch. Benadryl had no effect. Will be taking 5 mg prednisone p.o., and also icing down next.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Condition aggravated, Diarrhoea, Dizziness, Extra dose administered
Clinical narrative: About 2 hours after receiving my Moderna Booster shot I was severely hit with Diarrhea for 28 hours. I took Imodium to help slow it down. It?s been about 40 hours now and my stomach is still upset. Also I still have pain at the injection site with a golf ball size lump that seems to be getting smaller now. During the second day my pain in the arm was really bad. It was a whole lot worse then when I received my second dose of Moderna. In fact it was almost triple the pain. I also experienced being a little  dizzy and loopy the first day. These two symptoms were mild.  I also have  a faint headache that started about 20 hours after the Injection
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Injection site swelling, Pain in extremity
Clinical narrative: About 2 hours after receiving my Moderna Booster shot I was severely hit with Diarrhea for 28 hours. I took Imodium to help slow it down. It?s been about 40 hours now and my stomach is still upset. Also I still have pain at the injection site with a golf ball size lump that seems to be getting smaller now. During the second day my pain in the arm was really bad. It was a whole lot worse then when I received my second dose of Moderna. In fact it was almost triple the pain. I also experienced being a little  dizzy and loopy the first day. These two symptoms were mild.  I also have  a faint headache that started about 20 hours after the Injection
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram, Arthralgia, Blood test, Computerised tomogram, Diplopia
Clinical narrative: Erythemic hands (bilateral); enlarged veins; numbness, tingling, and swelling in hands and feet; pain in finger joints; fatigue; severe intractable headache since January with double vision and dizziness.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Electromyogram, Fatigue, Headache, Hypoaesthesia
Clinical narrative: Erythemic hands (bilateral); enlarged veins; numbness, tingling, and swelling in hands and feet; pain in finger joints; fatigue; severe intractable headache since January with double vision and dizziness.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Lumbar puncture, Magnetic resonance imaging, Ophthalmological examination, Paraesthesia, Peripheral swelling
Clinical narrative: Erythemic hands (bilateral); enlarged veins; numbness, tingling, and swelling in hands and feet; pain in finger joints; fatigue; severe intractable headache since January with double vision and dizziness.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Scan brain, Ultrasound Doppler, Vasodilatation, Venogram
Clinical narrative: Erythemic hands (bilateral); enlarged veins; numbness, tingling, and swelling in hands and feet; pain in finger joints; fatigue; severe intractable headache since January with double vision and dizziness.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Extra dose administered, Eye swelling, Fatigue, Injection site reaction
Clinical narrative: Patient presented to the pharmacy morning after day of adminitration with red and swollen eyes, injection site reaction and pruritus in face, chest, abdomen, thighs and back, very red area on all the abdomen area with deprived sleep. Also, patient reported being fatigue and lack of sleep due to a bad rash all over body.  Per patient, it started approximately 6 hours after the third COVID-19 vaccine from Moderna. assessed for difficulty breathing and swollen airways, and recommended patient to visit the closest urgent care to receive medical attention.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Ocular hyperaemia, Pruritus, Rash, Sleep deficit
Clinical narrative: Patient presented to the pharmacy morning after day of adminitration with red and swollen eyes, injection site reaction and pruritus in face, chest, abdomen, thighs and back, very red area on all the abdomen area with deprived sleep. Also, patient reported being fatigue and lack of sleep due to a bad rash all over body.  Per patient, it started approximately 6 hours after the third COVID-19 vaccine from Moderna. assessed for difficulty breathing and swollen airways, and recommended patient to visit the closest urgent care to receive medical attention.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Increased upper airway secretion, Rhinorrhoea, SARS-CoV-2 test negative
Clinical narrative: I have been having increased secretions and heavy mucous productions ever since reacting to the initial Covid vaccination. Initially secretions were noticed and  increased mucous shortly followed. This mucous and secretions have never been a normal for me and has been persistent since May.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Disturbance in attention, Fatigue, Feeling abnormal
Clinical narrative: Joint pain in both shoulders, both knees, both elbows, neck, both hands 24 hours every day, does not go away.  Lack of energy, easily fatigued, cannot focus or concentrate, brain fog, can?t remember simple things, diminished lung capacity. Lack of motivation due to physical symptoms.